- Home
- CTSO vs CRT Comparison
CTSO vs CRT Comparison
Compare CTSO & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- CRT
- Stock Information
- Founded
- CTSO 1997
- CRT 1991
- Country
- CTSO United States
- CRT United States
- Employees
- CTSO N/A
- CRT N/A
- Industry
- CTSO Medical/Dental Instruments
- CRT Oil & Gas Production
- Sector
- CTSO Health Care
- CRT Energy
- Exchange
- CTSO Nasdaq
- CRT Nasdaq
- Market Cap
- CTSO 51.6M
- CRT 60.9M
- IPO Year
- CTSO N/A
- CRT 1992
- Fundamental
- Price
- CTSO $1.15
- CRT $10.66
- Analyst Decision
- CTSO Strong Buy
- CRT
- Analyst Count
- CTSO 3
- CRT 0
- Target Price
- CTSO $4.67
- CRT N/A
- AVG Volume (30 Days)
- CTSO 147.4K
- CRT 27.0K
- Earning Date
- CTSO 03-06-2025
- CRT 01-01-0001
- Dividend Yield
- CTSO N/A
- CRT 8.01%
- EPS Growth
- CTSO N/A
- CRT N/A
- EPS
- CTSO N/A
- CRT 1.13
- Revenue
- CTSO $37,739,531.00
- CRT $7,711,133.00
- Revenue This Year
- CTSO $9.20
- CRT N/A
- Revenue Next Year
- CTSO $11.64
- CRT N/A
- P/E Ratio
- CTSO N/A
- CRT $9.73
- Revenue Growth
- CTSO 1.80
- CRT N/A
- 52 Week Low
- CTSO $0.70
- CRT $8.88
- 52 Week High
- CTSO $1.61
- CRT $17.72
- Technical
- Relative Strength Index (RSI)
- CTSO 55.74
- CRT 50.85
- Support Level
- CTSO $1.06
- CRT $10.23
- Resistance Level
- CTSO $1.61
- CRT $11.36
- Average True Range (ATR)
- CTSO 0.13
- CRT 0.34
- MACD
- CTSO 0.01
- CRT 0.01
- Stochastic Oscillator
- CTSO 29.34
- CRT 38.05
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States based trust. Its principal asset is the net profits interests. The net profits interests are derived from producing royalty, overriding royalty interests, and working interests properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.